The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Duck Virus Enteritis Vaccine Market Research Report 2024
Synopsis
Vaccine for Duck Virus Enteritis, A duck enteritis virus- vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks.
The global Duck Virus Enteritis Vaccine market was valued at US$ 67 million in 2023 and is anticipated to reach US$ 97.9 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Duck Virus Enteritis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duck Virus Enteritis Vaccine.
Report Scope
The Duck Virus Enteritis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Duck Virus Enteritis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Duck Virus Enteritis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ceva Santé Animale
Chengdu TECBOND Biological
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
International Duck Research Cooperative
MSD Animal Health (Merck)
Ringpu (Tianjin)Bio-Pharmacy
Veterinary Research Institute
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Duck
Others
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Duck Virus Enteritis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Duck Virus Enteritis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vaccine for Duck Virus Enteritis, A duck enteritis virus- vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks.
The global Duck Virus Enteritis Vaccine market was valued at US$ 67 million in 2023 and is anticipated to reach US$ 97.9 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Duck Virus Enteritis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duck Virus Enteritis Vaccine.
Report Scope
The Duck Virus Enteritis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Duck Virus Enteritis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Duck Virus Enteritis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ceva Santé Animale
Chengdu TECBOND Biological
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
International Duck Research Cooperative
MSD Animal Health (Merck)
Ringpu (Tianjin)Bio-Pharmacy
Veterinary Research Institute
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Duck
Others
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Duck Virus Enteritis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Duck Virus Enteritis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Duck Virus Enteritis Vaccine Market Overview
1.1 Product Overview and Scope of Duck Virus Enteritis Vaccine
1.2 Duck Virus Enteritis Vaccine Segment by Type
1.2.1 Global Duck Virus Enteritis Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Duck Virus Enteritis Vaccine Segment by Application
1.3.1 Global Duck Virus Enteritis Vaccine Market Value by Application: (2024-2030)
1.3.2 Duck
1.3.3 Others
1.4 Global Duck Virus Enteritis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Duck Virus Enteritis Vaccine Revenue 2019-2030
1.4.2 Global Duck Virus Enteritis Vaccine Sales 2019-2030
1.4.3 Global Duck Virus Enteritis Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Duck Virus Enteritis Vaccine Market Competition by Manufacturers
2.1 Global Duck Virus Enteritis Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Duck Virus Enteritis Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Duck Virus Enteritis Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Duck Virus Enteritis Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Duck Virus Enteritis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Duck Virus Enteritis Vaccine, Product Type & Application
2.7 Duck Virus Enteritis Vaccine Market Competitive Situation and Trends
2.7.1 Duck Virus Enteritis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Duck Virus Enteritis Vaccine Players Market Share by Revenue
2.7.3 Global Duck Virus Enteritis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Duck Virus Enteritis Vaccine Retrospective Market Scenario by Region
3.1 Global Duck Virus Enteritis Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Duck Virus Enteritis Vaccine Global Duck Virus Enteritis Vaccine Sales by Region: 2019-2030
3.2.1 Global Duck Virus Enteritis Vaccine Sales by Region: 2019-2024
3.2.2 Global Duck Virus Enteritis Vaccine Sales by Region: 2025-2030
3.3 Global Duck Virus Enteritis Vaccine Global Duck Virus Enteritis Vaccine Revenue by Region: 2019-2030
3.3.1 Global Duck Virus Enteritis Vaccine Revenue by Region: 2019-2024
3.3.2 Global Duck Virus Enteritis Vaccine Revenue by Region: 2025-2030
3.4 North America Duck Virus Enteritis Vaccine Market Facts & Figures by Country
3.4.1 North America Duck Virus Enteritis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Duck Virus Enteritis Vaccine Sales by Country (2019-2030)
3.4.3 North America Duck Virus Enteritis Vaccine Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Duck Virus Enteritis Vaccine Market Facts & Figures by Country
3.5.1 Europe Duck Virus Enteritis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Duck Virus Enteritis Vaccine Sales by Country (2019-2030)
3.5.3 Europe Duck Virus Enteritis Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Duck Virus Enteritis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Duck Virus Enteritis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Duck Virus Enteritis Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Duck Virus Enteritis Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Duck Virus Enteritis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Duck Virus Enteritis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Duck Virus Enteritis Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Duck Virus Enteritis Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Duck Virus Enteritis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Duck Virus Enteritis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Duck Virus Enteritis Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Duck Virus Enteritis Vaccine Sales by Type (2019-2030)
4.1.1 Global Duck Virus Enteritis Vaccine Sales by Type (2019-2024)
4.1.2 Global Duck Virus Enteritis Vaccine Sales by Type (2025-2030)
4.1.3 Global Duck Virus Enteritis Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Duck Virus Enteritis Vaccine Revenue by Type (2019-2030)
4.2.1 Global Duck Virus Enteritis Vaccine Revenue by Type (2019-2024)
4.2.2 Global Duck Virus Enteritis Vaccine Revenue by Type (2025-2030)
4.2.3 Global Duck Virus Enteritis Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Duck Virus Enteritis Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Duck Virus Enteritis Vaccine Sales by Application (2019-2030)
5.1.1 Global Duck Virus Enteritis Vaccine Sales by Application (2019-2024)
5.1.2 Global Duck Virus Enteritis Vaccine Sales by Application (2025-2030)
5.1.3 Global Duck Virus Enteritis Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Duck Virus Enteritis Vaccine Revenue by Application (2019-2030)
5.2.1 Global Duck Virus Enteritis Vaccine Revenue by Application (2019-2024)
5.2.2 Global Duck Virus Enteritis Vaccine Revenue by Application (2025-2030)
5.2.3 Global Duck Virus Enteritis Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Duck Virus Enteritis Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ceva Santé Animale
6.1.1 Ceva Santé Animale Corporation Information
6.1.2 Ceva Santé Animale Description and Business Overview
6.1.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ceva Santé Animale Duck Virus Enteritis Vaccine Product Portfolio
6.1.5 Ceva Santé Animale Recent Developments/Updates
6.2 Chengdu TECBOND Biological
6.2.1 Chengdu TECBOND Biological Corporation Information
6.2.2 Chengdu TECBOND Biological Description and Business Overview
6.2.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Portfolio
6.2.5 Chengdu TECBOND Biological Recent Developments/Updates
6.3 Institute of Animal Health and Veterinary Biologicals
6.3.1 Institute of Animal Health and Veterinary Biologicals Corporation Information
6.3.2 Institute of Animal Health and Veterinary Biologicals Description and Business Overview
6.3.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Portfolio
6.3.5 Institute of Animal Health and Veterinary Biologicals Recent Developments/Updates
6.4 Institute of Veterinary Preventive Medicine
6.4.1 Institute of Veterinary Preventive Medicine Corporation Information
6.4.2 Institute of Veterinary Preventive Medicine Description and Business Overview
6.4.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Portfolio
6.4.5 Institute of Veterinary Preventive Medicine Recent Developments/Updates
6.5 International Duck Research Cooperative
6.5.1 International Duck Research Cooperative Corporation Information
6.5.2 International Duck Research Cooperative Description and Business Overview
6.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Portfolio
6.5.5 International Duck Research Cooperative Recent Developments/Updates
6.6 MSD Animal Health (Merck)
6.6.1 MSD Animal Health (Merck) Corporation Information
6.6.2 MSD Animal Health (Merck) Description and Business Overview
6.6.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Portfolio
6.6.5 MSD Animal Health (Merck) Recent Developments/Updates
6.7 Ringpu (Tianjin)Bio-Pharmacy
6.6.1 Ringpu (Tianjin)Bio-Pharmacy Corporation Information
6.6.2 Ringpu (Tianjin)Bio-Pharmacy Description and Business Overview
6.6.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Portfolio
6.7.5 Ringpu (Tianjin)Bio-Pharmacy Recent Developments/Updates
6.8 Veterinary Research Institute
6.8.1 Veterinary Research Institute Corporation Information
6.8.2 Veterinary Research Institute Description and Business Overview
6.8.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Veterinary Research Institute Duck Virus Enteritis Vaccine Product Portfolio
6.8.5 Veterinary Research Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Duck Virus Enteritis Vaccine Industry Chain Analysis
7.2 Duck Virus Enteritis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Duck Virus Enteritis Vaccine Production Mode & Process
7.4 Duck Virus Enteritis Vaccine Sales and Marketing
7.4.1 Duck Virus Enteritis Vaccine Sales Channels
7.4.2 Duck Virus Enteritis Vaccine Distributors
7.5 Duck Virus Enteritis Vaccine Customers
8 Duck Virus Enteritis Vaccine Market Dynamics
8.1 Duck Virus Enteritis Vaccine Industry Trends
8.2 Duck Virus Enteritis Vaccine Market Drivers
8.3 Duck Virus Enteritis Vaccine Market Challenges
8.4 Duck Virus Enteritis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
